The global infant nutrition market is projected to grow significantly, reaching an estimated value of US$ 162.08 billion by 2035. This growth is supported by ongoing regulatory developments and advancements in product innovation. Market leaders, including companies like Danone, are focusing on premium medical nutrition products, which contribute to higher value growth despite demographic challenges.
The industry is experiencing a shift from volume-based sales to value-driven strategies. At the same time, generalist companies are exiting the market, leading to increased consolidation around specialized, clinically validated nutrition products. This trend is expected to shape the competitive landscape and drive further investment in high-margin infant nutrition solutions.
**Why this matters**
The shift towards premium and clinically supported infant nutrition products reflects changing consumer preferences and stricter regulatory standards. This evolution not only impacts market dynamics but also influences the availability and quality of nutrition options for infants globally. Understanding these trends is important for stakeholders, including manufacturers, healthcare providers, and policymakers, as they navigate the future of infant nutrition.
Source: NewsData